Transaction structured to achieve majority ownership through performance-based clinical and regulatory milestonesMarks first strategic ...
InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the instrumentation industry in ...
Dr. Shirishkumar Patel showcases how digital dentistry, CAD-CAM workflows, and biomaterial innovation are transforming care.
PITTSBURGH - Three new dentistry labs at the University of Pittsburgh School of Dental Medicine will give students and ...
RaySearch Laboratories AB offers significant market opportunities through its innovative software solutions for cancer radiation therapy, including RayStation, Raycare, RayIntelligence, and other ...
GraftAssureâ„¢ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...
This advancement has the potential to transform conventional "flat" clinical trial data into detailed quantum-resolved biological maps Tel Aviv, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Viewbix Inc.
Armed with some data from our friends at CrunchBase, I broke down the largest NYC Startup funding rounds in New York for ...
GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...
The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing ...
Learn more about whether Agilent Technologies, Inc. or Charles River Laboratories International, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results